Robert W Busby

4PUBLICATIONS
25CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 09, 2026
A MERTK-Targeting Antibody-Drug Conjugate Selectively Depletes M2 Tumor-Associated Macrophages and MERTK-Expressing Cancer Cells.

Shugaku Takeda, Subhasree Sridhar, Daniel Schefer

|Feb 06, 2026
Carboxylic Acid Bioisosteres of Creatine as Novel and Selective Substrate Competitive Inhibitors of the Creatine Transporter SLC6A8.

Eduardo J Martinez, Darren H Wong, Amish J Patel

|Dec 17, 2021
Metopimazine is primarily metabolized by a liver amidase in humans.

Robert W Busby, Xiaokun Cai, Sihyung Yang

|Oct 06, 2021
Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels.

Isabel Kurth, Norihiro Yamaguchi, Celia Andreu-Agullo

Pageof 1

Frequent Collaborators

3 joint publications

Sohail F Tavazoie

2 joint publications

Celia Andreu-Agullo

2 joint publications

Shugaku Takeda

2 joint publications

Masoud F Tavazoie